KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway

Figure 1

Elevated KAT5 expression correlates with poor survival in patients with thyroid carcinoma. TCGA database was used to analyze the correlation between KAT5 expression and T staging (A) or disease-specific survival rate (B, C) of patients with thyroid carcinoma.

(a)

(b)

(c)